Bank of America’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-5,000
Closed -$853K 7400
2019
Q4
$853K Sell
5,000
-6,500
-57% -$1.21M ﹤0.01% 4613
2019
Q3
$2.05M Buy
11,500
+2,500
+28% +$540K ﹤0.01% 4037
2019
Q2
$2.34M Hold
9,000
﹤0.01% 3916
2019
Q1
$2.57M Buy
+9,000
New +$2.99M ﹤0.01% 3782
2018
Q4
Sell
-20,000
Closed -$8.99M 7494
2018
Q3
$8.99M Hold
20,000
﹤0.01% 2587
2018
Q2
$8.18M Hold
20,000
﹤0.01% 2659
2018
Q1
$5.82M Sell
20,000
-10,000
-33% -$2.53M ﹤0.01% 2931
2017
Q4
$5.62M Buy
+30,000
New +$5.6M ﹤0.01% 3011

Other funds holding ABMD

Bank of America's ABMD Position: Q4 2022 in Review

Bank of America sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 209,427 shares — an estimated $51.4M sold.

Bank of America first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $75.6M in Q3 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Bank of America reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Bank of America sold 209,427 Abiomed Inc shares in Q4 2022, an estimated $51.4M.
  • Bank of America first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
  • Bank of America's Abiomed Inc position peaked at $75.6M in Q3 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Bank of America's 13F filing for Q4 2022, filed 10 Feb 2023.